Estimating the impact of antimicrobial resistance on the national economy
DOI:
https://doi.org/10.52556/2587-3873.2025.1(103).10Keywords:
antimicrobial resistance, Costs, Economic impactAbstract
Resistance to antimicrobial drugs (AMR) generates high costs at the level of the entire economy in the form of losses in the workforce and in the level of Gross Domestic Product. The literature review, which included articles published after 2018, was performed based on PubMed and Google Scholar with the use of keyword searches. Terms used for literature selection included AMR, economic impact of AMR, and costs of AMR. The ways of assessing the economic impact of AMR were highlighted. These referred to the evaluation of numerical reduction of the labor force, labor productivity, and Gross Domestic Product (GDP). To assess the economic impact of the AMR over GDP and workforce componence in the Republic of Moldova, we used data on the employment rate of the population, number of new cases with AMR, average length of stay in hospital per case with AMR and GDP per person per day. Antimicrobial resistance generates a large impact on the national economy. It contributes to a decrease in the employed workforce, in workforce productivity, and in GDP. In the Republic of Moldova the losses attributable to AMR cases identified through the period 2020-2022 account for 9370600 lei. Further development of national reporting on new cases of AMR will allow to draw a more accurate forecast on the trend of economic impact of AMR.
References
AHMAD, M., KHAN, A.U. Global economic impact of antibiotic resistance: A review. In: Journal of Global Antimicrobial Resistance. 2019; nr.19, pp.313-316. https://doi.org/10.1016/j.jgar.2019.05.024
2. AHMED, S.A., BARIS, E., GO D.S., LOFGREN, H., OSORIORODARTE, I., THIERFELDER, K. Assessing the Global Economic and Poverty Effects of Antimicrobial Resistance. [online] In: World Bank Group Policy Research Working Paper. 2017, nr. 8133. Disponibil: 3. https://documents1.worldbank.org/curated/en/190151498872848485/pdf/WPS8133.pdf. https://doi.org/10.1596/1813-9450-8133
4. AIT OUAKRIM, D., CASSINI, A., CECCHINI, M., PLAUCHORAS, D. The health and economic burden of antimicrobial resistance. In: European Journal of Public Health. 2020; nr.30 (Supplement_5). https://doi.org/10.1093/eurpub/ckaa165.1201
5. ANTON, M., PANTEA, L., BURDUNIUC, O., CHILIANU, M., BUCOV, V., ȚAPU L. Evaluation of costs related to antimicrobial resistance of priority Gram-negative bacili. In: One Health and Risk Management. 2024, vol. 5, nr.1, pp. 43-50. https://doi.org/10.38045/ohrm.2024.1.06
6. CALBO, E., BOIX-PALOP, L., GARAU, J. Clinical and economic impact of bacterial resistance: An approach to infection control and antimicrobial stewardship solutions. In: Current Opinion in Infectious Diseases. 2020; nr. 33(6), pp. 458-463. https://doi.org/10.1097/QCO.0000000000000694
7. DADGOSTAR, P. Antimicrobial resistance: implications and costs. In: Infection and Drug Resistance. 2019; nr.12, pp. 3903- 3910. https://doi.org/10.2147/IDR.S234610
8. FOUNOU, R.C., FOUNOU, L.L., ESSACK, S.Y. Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis. In: PLoS One. 2017; nr.12(12). https://doi.org/10.1371/journal.pone.0189621
9. HILLOCK, N.T., MERLIN, T.L., TURNIDGE, J., KARNON, J. Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform Policy.
10. In: Applied Health Economics and Health Policy. 2022, Vol.20. pp.1-8. https://doi.org/10.1007/s40258-022-00728-x
11. JIT, M., LIN, D.H., LUANGASANATIP, N., SANDMANN, F.,G. et al. Quantifying the economic cost of antibiotic resistance and the impact of related interventions: Rapid methodological review, conceptual framework and recommenda tions for future studies. In: BMC Medicine. 2020; nr. 18(1). https://doi.org/10.1186/s12916-020-1507-2
12. JONAS, O.. Drug-Resistant Infections: A Threat to Our Economic Future. 2017. [online] Disponibil: https://www.worldbank.org/en/topic/health/publication/drugresistant-infections-a-threat-to-our-economic-future [accesat 11 ianuarie 2022].
13. LEAL, J.R., CONLY, J., HENDERSON, E.A., MANNS, B.J. How externalities impact an evaluation of strategies to prevent antimicrobial resistance in health care organizations. In: Antimicrobial Resistance & Infection Control. 2017; nr. 6(1). https://aricjournal.biomedcentral.com/articles/10.1186/s13756-017-0211-2 https://doi.org/10.1186/s13756-017-0211-2
14. LEE, X.J., STEWARDSON, A.J., WORTH, L.J., GRAVES, N., WOZNIAK, T.M.. Attributable Length of Stay, Mortality
Risk, and Costs of Bacterial Health Care-Associated Infections in Australia: A Retrospective Case-cohort Study. In: Clinical Infectious Diseases. 2020, nr. 72(10). https://doi.org/10.1093/cid/ciaa1228
15. OGAWA A., V. Understanding the Economics of Microbial Threats: Proceedings of a Workshop. In: The National Academies Press. 2018. https://doi.org/10.17226/25224
16. NAYLOR N.R., ATUN R., ZHU N. et al. Estimating the burden of antimicrobial resistance: a systematic literature review. In: Antimicrobial Resistance & Infection Control. 2018; nr.7:58. https://doi.org/10.1186/s13756-018-0336-y
17. PULINGAM, T., PARUMASIVAM, T., GAZZALI, A.M. et al. Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome. In: European Journal in Pharmaceutical Sciences. 2021;170. https://doi.org/10.1016/j.ejps.2021.106103
18. SHRESTHA, P., COOPER, B.S., COAST, J. et al. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use. In: Antimicrobial Resistance & Infection Control. 2018; nr. 7(1). https://doi.org/10.1101/206656
19. SMALLWOOD, C., GALA, S., CHANDRAN, A., NAKAMACHI, Y., MORRIS. A. Examining the clinical and economic impact of antimicrobial resistance at acute care facilities: a practical tool. In: Value Heal. 2019; Vol.22, Supplement 2, p. S202. https://doi.org/10.1016/j.jval.2019.04.919
20. ZHEN, X., STÅLSBY, L., C., SUN, X., ZHU, N., GU, S., DONG, H. Economic burden of antibiotic resistance in China: a national level estimate for inpatients. In: Antimicrobial Resistance & Infection Control. 2021; nr. 10(1). https://doi.org/10.1186/s13756-020-00872-w
21. Biroul Național de Statistică. Forța de muncă în Republica Moldova. Ocupare și șomaj. [online] Disponibil: https://statistica.gov.md/ro [accesat: 1 iulie 2025].
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
